(Q47598661)

4 February 2018

title

ACE inhibition in secondary prevention: are the results controversial? (English)

1 reference

4 February 2018

author name string

Erik B Friedrich

series ordinal

1

1 reference

4 February 2018

Koon K Teo

series ordinal

2

1 reference

4 February 2018

Michael Böhm

series ordinal

3

1 reference

4 February 2018

publication date

16 January 2006

1 reference

4 February 2018

Clinical Research in Cardiology

published in

1 reference

4 February 2018

volume

95

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

page(s)

61-67

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/s00392-006-0334-6

exact match

0 references

cites work

Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00392-006-0334-6

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00392-006-0334-6

Angiotensin-Converting Enzyme Inhibitors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00392-006-0334-6

ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary Article

21 January 2018

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

12 December 2020

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

12 December 2020

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

12 December 2020

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

12 December 2020

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

ACE inhibition in stable coronary artery disease

1 reference

12 December 2020

Deaths: leading causes for 2001.

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

10.1007/S00392-006-0334-6

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018